SKI Market

A+| A| A-|

Indian Indices

Sensex

72,696.39 -1,836.57
( -2.46%)

Global Indices

Nasdaq

45,612.20 -430.24
(-0.93%)

Dow Jones

6,526.68 -100.81
(-1.52%)

Hang Seng

51,583.72 -1,788.81
(-3.35%)

Nikkei 225

9,923.24 4.91
(0.05%)

Forex

USD-INR

93.13 0.41
(0.44%)

EUR-INR

107.17 0.41
(0.39%)

GBP-INR

124.14 0.56
(0.45%)

JPY-INR

0.59 0.00
(0.73%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Concord Drugs Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

538965

INE858L01010

34.4189

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

144.85

76.77

EPS(TTM)

Face Value()

Div & Yield %

0.53

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	36.93	43.26	51.31	58.96	51.36	51.34
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	36.93	43.26	51.31	58.96	51.36	51.34
Other Income	0.01	0.01	0.01	0.10	3.86	0.12
Stock Adjustments	0.58	0.40	-0.52	2.31	-1.69	-0.52
Total Income	37.52	43.67	50.80	61.37	53.53	50.94
EXPENDITURE :
Raw Materials	28.22	33.71	40.36	44.41	41.28	42.06
Power & Fuel Cost	0.00	0.00	0.00	0.00	0.00	0.77
Employee Cost	3.31	3.87	3.55	4.14	3.47	3.27
Other Manufacturing Expenses	0.34	0.39	0.44	0.43	0.60	0.40
Selling & Administrative Expenses	1.81	1.95	2.05	1.52	1.03	0.95
Miscellaneous Expenses	0.06	0.07	0.06	5.19	0.07	0.04
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	33.74	39.99	46.46	55.67	46.45	47.48
Operating Profit	3.78	3.69	4.35	5.69	7.08	3.46
Interest	1.72	1.59	1.62	1.68	1.42	1.54
Gross Profit	2.06	2.10	2.73	4.01	5.66	1.92
Depreciation	1.42	1.54	1.60	1.76	1.37	1.46
Profit Before Tax	0.64	0.56	1.13	2.25	4.29	0.46
Tax	0.19	0.20	0.35	0.67	0.47	0.12
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.16	-0.06	-0.11	-0.02	0.54	0.01
Reported Net Profit	0.30	0.42	0.89	1.59	3.28	0.33
Extraordinary Items	0.00	0.00	0.00	0.00	2.88	0.00
Adjusted Net Profit	0.30	0.42	0.89	1.59	0.40	0.33
Adjustment below Net Profit	0.00	0.00	0.00	0.01	0.00	0.00
P & L Balance brought forward	14.82	14.40	13.51	11.91	8.63	8.30
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	15.11	14.82	14.40	13.51	11.91	8.63
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	0.30	0.42	0.96	1.82	3.75	0.38
Earnings Per Share(Adj)-Unit Curr	0.30	0.42	0.96	1.82	3.75	0.38
Book Value-Unit Curr	34.11	33.82	33.43	32.44	30.61	26.86
Book Value(Adj)-Unit Curr	34.11	33.82	33.43	32.44	30.61	26.86

72,696.39 -1,836.57 ( -2.46%)

45,612.20 -430.24 (-0.93%)

6,526.68 -100.81 (-1.52%)

51,583.72 -1,788.81 (-3.35%)

9,923.24 4.91 (0.05%)

93.13 0.41 (0.44%)

107.17 0.41 (0.39%)

124.14 0.56 (0.45%)

0.59 0.00 (0.73%)